• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY S HIV AG/AB COMBO REAGENT KIT; HUMAN IMMUNODEFICIENCY VIRUS TYPES 1 AND 2 AG, AB (P24) AND SYNTHETIC PEPTIDES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY S HIV AG/AB COMBO REAGENT KIT; HUMAN IMMUNODEFICIENCY VIRUS TYPES 1 AND 2 AG, AB (P24) AND SYNTHETIC PEPTIDES Back to Search Results
Catalog Number 06P01-55
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/15/2021
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow up report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 06p01-55 that has a similar product distributed in the us, list number 06p01-60.
 
Event Description
The customer reported an increase in false repeat reactive alinity s hiv ag/ab combo results on multiple patients.Results provided: date (b)(6)2021; id (b)(6); initial (b)(6); repeat (b)(6); (s/co) (b)(6).No impact to patient management was reported.
 
Manufacturer Narrative
Section b5 additional patient data provided: (b)(6) 2021 1.2.41, 1.55, 1.52.4.1.52, 1.11, 1.19.10.3.11, 1.33, 1.28.14.1.04, 1.13, 1.22.(b)(6) 2021 1.2.22, 1.00, 0.99.
 
Event Description
The customer reported an increase in false repeat reactive alinity s hiv ag/ab combo results on multiple patients.Results provided: date id initial, repeat, (s/co).(b)(6) 2021.1.1.13, 1.43, 1.39.2.1.11, 1.61, 1.47.4.1.04, 1.54, 1.52.5.1.26, 2.04, 1.9.6.1.2, 1.9, 1.88.7.1.3, 2.41, 2.51.(b)(6) 2021 1.1.41, 1.45, 1.46.2.1.09, 1.09, 1.08.3.1.25, 1.61, 1.59.4.0.9, 1.17, 1.17.6.0.86, 1.07, 1.1.(b)(6) 2021 1.1.22, 1.74, 1.75.2.1.48, 1.55, 1.53.3.1.12, 1.17, 1.17.(b)(6) 2021 1.5.14, 4.77, 5.04.(b)(6) 2021 1.2.2, 1.73, 1.86.2.1.08, 1.06, 1.23.(b)(6) 2021 1.2.41, 1.55, 1.52.4.1.52, 1.11, 1.19.10.3.11, 1.33, 1.28.14.1.04, 1.13, 1.22.(b)(6) 2021 1.2.22, 1.00, 0.99.No impact to patient management was reported.
 
Manufacturer Narrative
After further evaluation, the suspect medical device was changed to alinity s, list 6p16 (irving, tx as manufacturing site) and submitted under manufacturer report numbers 1628664-2022-00007-00 and 1628664-2022-00005-00.All further information will be documented under mdr numbers 1628664-2022-00007-00 and 1628664-2022-00005-00.Section g1 updated contact information.
 
Event Description
The customer reported an increase in false repeat reactive alinity s hiv ag/ab combo results on multiple patients.Results provided: date id initial repeat (s/co) (b)(6) 2021.1.1.13 1.43 1.39, 2.1.11 1.61 1.47, 4.1.04 1.54 1.52, 5.1.26 2.04 1.9, 6.1.2 1.9 1.88, 7.1.3 2.41 2.5.1 (b)(6) 2021 1.1.41 1.45 1.46, 2.1.09 1.09 1.08, 3.1.25 1.61 1.59, 4.0.9 1.17 1.17, 6.0.86 1.07 1.1.(b)(6) 2021 1.1.22 1.74 1.75, 2.1.48 1.55 1.53, 3.1.12 1.17 1.17.(b)(6) 2021 1.5.14 4.77 5.04, 01.12.2021 1.2.2 1.73 1.86, 2.1.08 1.06 1.23.(b)(6) 2021 1.2.41 1.55 1.52, 4.1.52 1.11 1.19, 10.3.11 1.33 1.28, 14.1.04 1.13 1.22.(b)(6) 2021 1.2.22 1.00 0.99 no impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY S HIV AG/AB COMBO REAGENT KIT
Type of Device
HUMAN IMMUNODEFICIENCY VIRUS TYPES 1 AND 2 AG, AB (P24) AND SYNTHETIC PEPTIDES
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford, IL N39 E-932
2246682940
MDR Report Key12984620
MDR Text Key290146815
Report Number3002809144-2021-00696
Device Sequence Number1
Product Code QHM
Combination Product (y/n)N
Reporter Country CodeHR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 02/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number06P01-55
Device Lot Number29500BE00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/24/2021
Initial Date FDA Received12/13/2021
Supplement Dates Manufacturer Received12/14/2021
02/01/2022
Supplement Dates FDA Received01/06/2022
02/03/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY S SYSTEM, 06P16-01, (B)(6); ALNTY S SYSTEM, 06P16-01, (B)(6); ALNTY S SYSTEM, 06P16-01,(B)(6)
-
-